Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
bFGF Organism Protein Sponge After Endoscopic Transethmoidal Optic Canal Decompression for Traumatic Optic Neuropathy
ChiCTR2000038724Phase 4Not yet recruiting
- Sponsor
- Eye Hospital of Wenzhou Medical University
- Start
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in traumatic optic neuropathy (TON) comparing ETOCD + bFGF group with ETOCD only (placebo sponge) group (2 arms). Primary endpoint: Visual acuity. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
trafermin
03
Conditions
traumatic optic neuropathy (TON)
Beyond the preview
Go deeper on ChiCTR2000038724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038724.